editor
1,352
edits
Changes
no edit summary
| start =
* '''Day 8:''' start administration of fluvoxamine in a dosage of 50 mg/day.
{{Day22NoBloodlevelvortioxetine}}<ref name="vortiswitch"> {{Pubmed|24570588 |Katona et al. New generation multi-modal antidepressants: focus on vortioxetine for major depressive disorder. 2014 2014 Feb 19;10:349-54}}</ref> <ref name="informatorium">{{KNMP|vortioxetine}}</ref>
| info =
* {{theorSS}}
* Fluvoxamine is a inhibitor of CYP2C9, which metabolizes vortioxetine. }}
